For path_MSH2 carriers with previous CRC the risk of metachronous CRC by the age of 75 years was significantly higher (53.4% (95% c.i. 46.4% to 60.7%)) than the risk of a first CRC (P < 0.001). The gene discussed is MSH2; the disease is colorectal carcinoma.